(Q28195842)

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Cardiology and cardiovascular medicine

30 December 2023

main subject

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

30 December 2023

4

Andrzej Szczeklik

0 references

Filip Mejza

2

object named as

Filip Mejza

0 references

Adam Cmiel

3

object named as

Adam Cmiel

1 reference

Europe PubMed Central

PubMed publication ID

12730088

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730088

30 December 2023

author name string

Ewa Tuleja

Arteriosclerosis, Thrombosis, and Vascular Biology

1

0 references

language of work or name

English

0 references

publication date

1 June 2003

0 references

published in

0 references

volume

23

0 references

issue

6

0 references

page(s)

1111-5

0 references

cites work

The coxibs, selective inhibitors of cyclooxygenase-2.

1

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

30 December 2023

2

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

30 December 2023

3

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

30 December 2023

4

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Risk of cardiovascular events associated with selective COX-2 inhibitors

30 December 2023

5

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Biomedicine. Back to an aspirin a day?

30 December 2023

7

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

30 December 2023

Acta medica Scandinavica

12

223

187

1988

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects

30 December 2023

13

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Reasons for resistance to aspirin in cardiovascular disease

30 December 2023

14

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man

30 December 2023

15

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2

30 December 2023

16

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.

30 December 2023

18

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Role of prostacyclin in the cardiovascular response to thromboxane A2

30 December 2023

19

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

30 December 2023

20

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Cyclooxygenase-2 and atherosclerosis

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits

30 December 2023

22

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Cyclooxygenase-2 inhibition and cardiovascular events

30 December 2023

24

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

30 December 2023

26

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Images in cardiovascular medicine. Unusual form of truncus arteriosus associated with 22q11 deletion

30 December 2023

29

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

30 December 2023

30

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

30 December 2023

31

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

30 December 2023

33

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

30 December 2023

34

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Association between naproxen use and protection against acute myocardial infarction

30 December 2023

35

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

30 December 2023

36

1 reference

https://api.crossref.org/works/10.1161/01.ATV.0000074879.19006.51

30 December 2023

Identifiers